Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma

AIM: Neoadjuvant treatment of locally advanced disease with BRAF inhibitors is expected to increase the likelihood of a R0 resection. We present six patients with stage III unresectable melanoma, neoadjuvantly treated with BRAF inhibitors. METHODS: Patients with unresectable, BRAF-mutated, stage III...

Descripción completa

Detalles Bibliográficos
Autores principales: Faut, Marloes, Jalving, Mathilde, Diercks, Gilles F, Hospers, Geke A, van Leeuwen, Barbara L, Been, Lukas B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240848/
https://www.ncbi.nlm.nih.gov/pubmed/30459939
http://dx.doi.org/10.2217/mmt-2018-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240848/
https://www.ncbi.nlm.nih.gov/pubmed/30459939
http://dx.doi.org/10.2217/mmt-2018-0002

Ejemplares similares